Do antihistone autoantibodies reflect disease activity in linear scleroderma? [2]

Archives of Dermatology

Volumn 140, Issue 6, 2004, Pages 759-760

  El Azhary, Rokea A ^a   Aponte, Carol C ^b   Nelson, Audrey M ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ANTIBODY; HYDROXYCHLOROQUINE SULFATE; IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; CASE REPORT; CHILD; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; MALE; PRIORITY JOURNAL; SCLERODERMA; TREATMENT OUTCOME;

AUTOANTIBODIES; FOLLOW-UP STUDIES; HISTONES; HUMANS; SCLERODERMA, LOCALIZED; SKIN DISEASES;

EID: 2942620864     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.6.759     Document Type: Letter

References (5)

1. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol. 1994;31:567-571.
2. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol. 1994;130:1273-1277.
3. Sato S, Ihn H, Soma Y, et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum. 1993;36:1137-1141.
4. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr. 2000; 136:91-95.
5. Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed. 2001;17:149-155.